Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,309 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairment.
Gupta SK, Kantesaria B, Wang Z. Gupta SK, et al. J Clin Pharmacol. 2007 Oct;47(10):1283-91. doi: 10.1177/0091270007306561. J Clin Pharmacol. 2007. PMID: 17906161 Clinical Trial.
Effect of renal function on the pharmacokinetics of palifermin.
Gillespie B, Zia-Amirhosseini P, Salfi M, Kakkar T, Wang J, Gupta S, Smith B, Robson R, Sullivan JT. Gillespie B, et al. J Clin Pharmacol. 2006 Dec;46(12):1460-8. doi: 10.1177/0091270006292705. J Clin Pharmacol. 2006. PMID: 17101745 Clinical Trial.
Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease.
Wasserman RL, Irani AM, Tracy J, Tsoukas C, Stark D, Levy R, Chen J, Sorrells S, Roberts R, Gupta S. Wasserman RL, et al. Clin Exp Immunol. 2010 Sep;161(3):518-26. doi: 10.1111/j.1365-2249.2010.04195.x. Clin Exp Immunol. 2010. PMID: 20550549 Free PMC article. Clinical Trial.
Population pharmacokinetics of peginterferon alfa-2b in pediatric patients with chronic hepatitis C.
Xu C, Gupta S, Krishna G, Cutler D, Wirth S, Galoppo C, Ciocca M, Kolz K, Noviello S, Sniukiene V. Xu C, et al. Eur J Clin Pharmacol. 2013 Dec;69(12):2045-54. doi: 10.1007/s00228-013-1574-9. Epub 2013 Aug 24. Eur J Clin Pharmacol. 2013. PMID: 23975236 Clinical Trial.
A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.
Glue P, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, Salfi M, Jacobs S, Clement RP. Glue P, et al. Among authors: gupta sk. Hepatology. 2000 Sep;32(3):647-53. doi: 10.1053/jhep.2000.16661. Hepatology. 2000. PMID: 10960463 Clinical Trial.
Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group.
Glue P, Fang JW, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, Salfi M, Jacobs S. Glue P, et al. Among authors: gupta sk. Clin Pharmacol Ther. 2000 Nov;68(5):556-67. doi: 10.1067/mcp.2000.110973. Clin Pharmacol Ther. 2000. PMID: 11103758 Clinical Trial.
Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C.
Jen JF, Glue P, Ezzet F, Chung C, Gupta SK, Jacobs S, Hajian G. Jen JF, et al. Among authors: gupta sk. Clin Pharmacol Ther. 2001 Jun;69(6):407-21. doi: 10.1067/mcp.2001.115872. Clin Pharmacol Ther. 2001. PMID: 11406738 Clinical Trial.
Pharmacokinetics of an everninomicin (SCH 27899) in mice, rats, rabbits, and cynomolgus monkeys following intravenous administration.
Lin C, Gupta S, Loebenberg D, Cayen MN. Lin C, et al. Antimicrob Agents Chemother. 2000 Apr;44(4):916-9. doi: 10.1128/aac.44.4.916-919.2000. Antimicrob Agents Chemother. 2000. PMID: 10722491 Free PMC article.
Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study.
Gupta S, Banfield C, Kantesaria B, Marino M, Clement R, Affrime M, Batra V. Gupta S, et al. Clin Ther. 2001 Mar;23(3):451-66. doi: 10.1016/s0149-2918(01)80049-7. Clin Ther. 2001. PMID: 11318079 Clinical Trial.
Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C.
Jen JF, Glue P, Gupta S, Zambas D, Hajian G. Jen JF, et al. Ther Drug Monit. 2000 Oct;22(5):555-65. doi: 10.1097/00007691-200010000-00010. Ther Drug Monit. 2000. PMID: 11034261
3,309 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback